Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs
Citations Over TimeTop 10% of 2017 papers
Abstract
Abstract Therapeutic drug monitoring (TDM) of immunosuppressive drugs (ISDs) with a narrow therapeutic index is an increasingly popular tool for minimizing drug toxicity while maximizing the prevention of graft loss and organ rejection. This review focuses on trends regarding analytical methods for the TDM of ISDs since 2011. The five most commonly prescribed immunosuppressive medications are critically reviewed: cyclosporine A, tacrolimus, sirolimus (rapamycin), everolimus, and mycophenolic acid. This review introduces the general background of TDM and ISDs and presents the recent developments in using liquid chromatography–tandem mass spectrometry (LC–MS/MS) and immunoassays for the TDM of ISDs. Finally, a future perspective for these analytical methods is briefly discussed.
Related Papers
- → Sirolimus-tacrolimus combination immunosuppression(2000)329 cited
- → Everolimus: A Guide to Its Use in Liver Transplantation(2013)8 cited
- → Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the Simcer Study(2016)4 cited
- → Conversion between sirolimus and everolimus in heart transplant recipients(2023)1 cited